NMR-based metabolomics as a quality control tool for herbal products  by Heyman, H.M. & Meyer, J.J.M.
Available online at www.sciencedirect.com
South African Journal of Botany 82 (2012) 21–32
www.elsevier.com/locate/sajbReview
NMR-based metabolomics as a quality control tool for herbal products
H.M. Heyman ⁎, J.J.M. Meyer
Department of Plant Science, University of Pretoria, Pretoria 0002, South AfricaAvailable online 16 May 2012Abstract
The full potential of the herbal market is mainly not realised due to the lack of knowledge of the chemical composition of most herbal products.
The growth potential of the herbal medicine industry can only be achieved if the composition of herbal medicine is standardised to ensure proper
quality control and accountability. Plant-based nuclear magnetic resonance metabolomics is one such way of ensuring quick and reliable quality
control and metabolite proﬁling to ensure quality and reproducibility of herbal medicine. Nuclear magnetic resonance-based metabolomics is
robust and relatively easy to use, thus ensuring that herbal medicine can be veriﬁed and quality controlled much quicker and more accurate than is
currently the case. Although nuclear magnetic resonance is not as sensitive as other analytical techniques such as liquid chromatography and gas
chromatography–mass spectroscopy, it is far more reproducible, non-destructive, covers a much wider dynamic range and sample preparation is
simpler and quicker to use. Economical development of herbal medicine and the use of nuclear magnetic resonance-based metabolomics should go
hand in hand for a better future for herbal medicine. In this review an introduction is given to herbal extracts as therapeutic agents and to the quality
control aspects of herbal medicine by means of metabolomics. The experimental methodology for plant metabolomics which covers extraction, nuclear
magnetic resonance analysis and multivariate data analysis is also discussed. Some examples are given on the possible applications of nuclear magnetic
resonance-based metabolomics in the industry and ﬁnally the future of nuclear magnetic resonance-based metabolomics is discussed regarding
advances in research and development.
© 2012 SAAB. Published by Elsevier B.V. All rights reserved.
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1.1. Herbal extracts as therapeutic agents
Traditional herbal medicine has been used over millennia in
many different forms and is still being used as primary health care
in many underdeveloped and developing countries. In 1983,
Bannerman et al., found that up to 70% of the world's population
was using plants for medicinal purposes and mainly as their
primary health care. In 1994, Farnsworth reported that approx-
imately 60% of the world was at that point using plants for
medicinal purposes. This is still probably the case today and is
given as such in the WHO fact file on Traditional Medicine
(WHO, 2008). It is also stated in this document that in many
African and Asian countries up to 80% of the population is still
using medicinal plants in primary health care. It is not only the
developing countries that are using plants for medicinal purposes,
but the use of herbal medicine (HM) in developed countries,
especially the USA and Germany, is on the increase. Increases in
the market showed growth rates of between 5 and 18% per year
from 1985 to 1995 (Grünwald, 1995). The average imports into
the USA and Hong Kong reached more than $220 million and
$167 million respectively in the period from 2004 to 2008. The
leading exporters in the same period were China and India with a
value of more than $348 million and $93 million, respectively
(Lubbe and Verpoorte, 2011).
In the document of the WHO (2000), “General Guidelines
for Methodologies on Research and Evaluation of Traditional
Medicine”, the following statement was issued concerning tra-
ditional medicine: “Despite its existence and continued use over
many centuries, and its popularity and extensive use during the
last decade, traditional medicine has not been officially recog-
nised in most countries. Consequently, education, training and
research in this area have not been accorded due attention and
support. The quantity and quality of the safety and efficacy data
on traditional medicine are far from sufficient to meet the criteria
needed to support its use world-wide. The reasons for the lack of
research data are due to not only health care policies, but also to
lack of adequate or accepted researchmethodology for evaluating
traditional medicine”.
The usual assessment of HM on the basis of identifying one
or two biomarkers of pharmacologically active constituents in
the herbal product does not give a holistic view of the product as
the activity is usually due tomultiple constituents working together
to give the activity of the product. It is therefore necessary that HM
be investigated to determine most of the phytochemical constit-
uents contained in the product, ensuring that the bioactivities are
better understood. This will also help to identify and understandthe possible side effects of the active constituents and thus finally
enhancing quality control of the HM product. Good quality control
practices will confirm the reliability and repeatability of pharma-
cological and clinical research and finally more credible interest
in the HM product (Bauer, 1998; Raven et al., 1999; Yan et al.,
1999).
When comparing conventional drugs to herbal medicine, it is
necessary to distinguish between these two forms of therapeutic
agents as well as how these are administered. The administering
of a pure chemical and that of a plant extract containing the same
chemical entity is essentially different. The difference is mainly
due to the complexity of a plant extract that introduces many
variables to conventional phyto-medicinal research, which could
possibly contribute to chemical complexity and bioactivity. This
is very clearly illustrated in the study of Weathers et al. (2011), in
which the administration of plant material (e.g. Artemisia annua)
versus pure drug (e.g. artemisinin) revealed that the bioavailabil-
ity from the leaves was 45 times more than that of the pure drug.
Thus the complexity of the plant extract could have contributed to
the increased bioavailability and thus the bioactivity.
As our analytical techniques as well diagnostic techniques
are being improved we are once again faced with the reality that
living organisms and life in general is complex. The fact that
science is only starting to comprehend the different subtle, varied
and complex mechanisms in many of the biochemical systems in
organisms, is a confirmation that we can not ignore the possibility
of complex herbal medicine contributing greatly as therapeutic
agents (Wills et al., 2000).
New therapeutic herbal agents have delivered variability in the
efficacy in treating especially recurrent and chronic infections. It is
also noteworthy to consider that a number of plant extracts con-
taining a number of bioactive compounds may be used not only to
provide important combination therapies which affect multiple
pharmacological targets but also at the same time to provide
clinical efficacies which are normally beyond single compound-
based drugs capabilities (Schmidt et al., 2007; Williamson, 2001).1.2. Quality control and quality assurance of herbal medicine
Quality control (QC) and the standardisation of herbal extracts
are very important to protect the integrity of the herbal extracts for
pharmaceutical quality. It also forms part of a prerequisite for the
reproducibility of the effect of the active ingredients from one
batch to another (Saller and Reichling, 2002).
In order to comply with legal conditions in Europe with respect
to effectiveness, quality and safety, it is required to follow certain
steps of standardisation (Ulrich-Merzenich et al., 2007). The five
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scribed as:(1) Definitive authentication and taxonomic assignment e.g.
through DNA-fingerprinting and DNA bar-coding.
(2) Isolation and structural elucidation of all major constituents
of the herbal drug.
(3) Identification of the true bioactive constituents.
(4) Multi-extract mixtures; standardisation of the single extracts
or 3D HPLC fingerprint analyses of the multi-compound
extracts.
(5) Global harmonisation of standardisation criteria under the
umbrella of the International Federation of Pharmaceutical
Manufacturers Associations (IFPMA).
It is thus clear that it is very important to standardise the HM
products to comply with international standards. Standardisation
of HM products is very difficult to achieve as there are numerous
variables that will influence the standardisation process of HM
products. It is therefore necessary to optimise all aspects of culti-
vation, harvesting, sample preparation and sample processing to
ensure reproducibility and eventually standardisation of the HM
product.
Chromatographic and spectroscopic techniques should be
incorporated to ensure that sufficient quality control measures are
implemented. By using chromatography and spectroscopy it is
possible to analyse the full HM product and thus generate a
standardised “metabolic fingerprint” of the specific HM product
and thus the HM as a whole can be regarded as the “active
constituent” with such a characteristic “metabolic fingerprint”.
Metabolic profiling can then be incorporated to identify the
constituents that make up the “metabolic fingerprint” (Bailey et
al., 2002; Tyler, 1999). In compliance with the five steps of the
European herbal standardisation regulation and the German
concept of phyto-equivalence, chromatographic and spectroscop-
ic techniques are ideal components in standardising HM products
as well as comparing the chemical profile of HM products to
clinically proven reference products. This will ensure much more
accurate, reliable and repeatable analyses of the HM products on
the market (Tyler, 1999).
It should globally be considered to evaluate HM products
not only on a few biomarkers, but also on multiple constituents
in HM products (Liang et al., 2004). It is also necessary to note
that these chemical fingerprints obtained from chromatography
or spectroscopy contribute significantly in determining the
similarities and differences between various samples (Valentão
et al., 1999; Xie, 2001).
Recent developments have led to chemometric approaches
being used together with data from spectroscopy and chromatog-
raphy. When these are used in combination with chemometrics
evenmore accurate data is obtained to establish the integrity of the
HM product and observations concerning the similarities and
differences of the HMdata. The power of chemometrics lies in the
different dimensional observations that are used to explain the
similarities and differences of the data and subsequently present-
ing it in a user-friendly graphical manner (Liang et al., 2004).1.3. Metabolomic techniques
Metabolomics can best be described as a comprehensive
quantitative and qualitative analysis of ‘all’ metabolites present
in a specific cell, tissue or organism. Metabolomics can thus be
defined as “the systematic study of the distinctive chemical
fingerprints that specific cellular processes leave behind” — and
even more specifically, the study of the metabolite profile of ‘all’
the small molecules in an organism (Daviss, 2005). Thus, the
metabolome is a collective representation of all the metabolites in
a biological organism, which are the end-products of its gene
expression (Van der Kooy et al., 2009).
Unlike the other ‘-omics’ approaches like genomics, tran-
scriptomics and proteomics, a one-step analysis and display of all
metabolites in a metabolome is not possible due to the enormous
complexity in biological systems, especially in that of plant sys-
tems (Sumner et al., 2003). Metabolic analysis can be divided
into four major areas:(1) Targeted compound analysis— quantification of specific
metabolites.
(2) Metabolic profiling — quantitative and qualitative deter-
mination of a group of related compounds or of specific
metabolic pathways.
(3) Metabolomic fingerprinting — sample classification by
rapid global analysis.
(4) Metabolomic analysis — this involves the quantitative and
qualitative analysis of ‘all’metabolites (which is not possible
yet).
The techniques used in all four areas are multidisciplinary and
make use of many different complementary analytical methods,
some rely on chromatographic separation and others do not
comprise any separation step and represent a global view of the
sample (Ulrich-Merzenich et al., 2007).
The two major approaches in metabolomics are targeted
(biased) and global (unbiased) metabolite analyses. Targeted
metabolite analysis or metabolite profiling targets a subset of
metabolites in a sample instead of analysing the complete
metabolome.Metabolome analyses use a particular set of analytical
techniques (Fig. 1) such as Fourier transformed infrared spectros-
copy (FT-IR), gas chromatography–mass spectrometry (GC–MS),
liquid chromatography–mass spectrometry (LC–MS), nuclear
magnetic resonance (NMR), capillary electrophoresis–mass spec-
trometry (CE–MS), and thin layer chromatography (TLC) (Shyur
and Yang, 2008). Recent advances made in analytical chemistry
for small mass compound detection and characterisation, such as
MS and high-field NMR, coupled with modern multivariate
statistics have led to a highly efficient system for comprehensive
analysis of the metabolite data matrices generated by metabolomic
experiments (Lindon et al., 2007). A comparison of metabo-
lomic techniques is illustrated in Fig. 2 and these need to be
taken into account when a new metabolomic investigation is
being considered. In this review the focus is on the use of the
NMR technique because of its rapid and robust characteristics that
are necessary for industrial quality control purposes.
Fig. 1. Key features of the technologies used in metabolomics for herbal medicine research (Shyur and Yang, 2008).
Fig. 2. A comparison of the relative sensitivities of various metabolomic
techniques. NMR has rapid analysis time but suffers from lower sensitivity thus
allowing visualisation only of the more concentrated metabolites. GC–MS and
HPLC–MS provide good selectivity and sensitivity. CE-LIF (laser induced
fluorescence) provides very high sensitivity but lower selectivity.
Based on work from Sumner et al., 2003.
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2.1. Collection and extraction of the herbal product
Conventional collection of plant material has to take many
factors into account that may have a significant influence on the
integrity of the sample (e.g. collection time, season, method,
soil, weather, etc.). Preparation of herbal plant material differs from
the conventional preparation for metabolomics analysis as the HM
material is already processed and samples are taken from the
production line as a processed HMproduct. It is still very important
to collect a good representation of the herbal plant material that will
be used as the herbal product. Good manufacturing practices
(GMP) as well as good laboratory practices (GLP) need to be
adhered to as not to introduce any unwanted variation in the
data.
The extraction procedure may lead to biochemical reactions
taking place in the plant material that will result in a change in
the metabolome of the sample. Thus it is important to take into
account the preparation method of the selected HM. Preparation
of the sample for analysis should follow the preparation method of
the selected HM as it would be prepared for consumption by the
Fig. 3. 600 MHz 1H NMR spectrum of 2:1:1 (CHCl3:CH3OH:H2O) extract of
air-dried Helichrysum adenocarpum subs. adenocarpum DC in D2O (Heyman
et al., 2009).
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to release the metabolites from the cells, this is best done at low
temperature and/or in the presence of a solvent. Making use of
ultrasonication has been found to be the best method to use for the
efficient breakage of cells of the plant material and thus yielding
the largest quantity and range of metabolites to be analysed (Jaki et
al., 2006).
To date there is no single extraction method that can extract all
the metabolites in an organism. Due to the polarity and pH of the
solvents used a limited range of metabolites can be extracted. This
can be avoided to a certain degree by applying a two-phase solvent
system consisting of chloroform:methanol:water (2:1:1) to extract
compounds from the plant material both of polar and non-polar
nature in a single extraction (Choi et al., 2004a, 2004b, 2005;
Suhartono et al., 2005).
The two-phase solvent extraction system is very complex and
it could affect the composition of the samples and result in the loss
and degradation of the sample due to the longer preparation time.
Using this method it makes it more challenging when faced with
large number of samples to be analysed. This prompted the use of
a two-phase deuterated solvent system that is quicker and reduces
the sampling handling time. This method provides much better
results and NMR spectra however, it is much more expensive
(Hendrawati et al., 2006; Le Gall et al., 2004; Liang et al., 2006;
Ward et al., 2007; Widarto et al., 2006).
The use of single solvent systems to extract metabolites out
of plant material has been done in some studies, but using a
combination of solvents has now become the preferred method
for extraction. Using for example a combination of D2O and
CD3OD in different ratios (aligned with the aims of the study) has
shown to extract more diverse metabolites from plant material.
Themajority of studies use a combination of CD3OD andKH2PO4
buffer (to avoid possible fluctuations in chemical shifts of signals
in the NMR spectra) in D2O with a pH of 6 in order to extract an
extensive range of metabolites which might include, phenolics,
terpenoids, fatty acids, organic acids, carbohydrates and amino
acids, in only one extraction step. The direct extraction method
with deuterated solvents saves time and makes it feasible to
analyse a large number of samples (Hendrawati et al., 2006; Kim
et al., 2005; Liang et al., 2006; Van der Kooy et al., 2009;
Widarto et al., 2006).
As discussed above, when focussing on a more specific group
of metabolites, for example in commercial herbal preparations, a
more targeted approach and extraction procedure could be
followed to be able to use the spectral data to evaluate the herbal
products' content with the utmost accuracy.
A general guide for the two-phase solvent extraction of plant
material would be to start with the grinding of dried plant
material, extraction in appropriate two-phase solvent system (e.g.
chloroform:methanol:water), after which the plant material can
be further homogenised (e.g. vortexing, sonication, etc.). The
extraction procedure should be repeated at least twice, to increase
the yield of extraction. After the extraction and filtration the
organic and aqueous layers will need to be separated and be dried
under vacuum. The samples can then be re-dissolved in the
deuterated solvents (0.7–1.0 ml), after which 1H NMR analysis
can be conducted (Kim et al., 2005).If deuterated solvents have been used, the extracts will be
centrifuged and the supernatant be transferred to NMR tubes
and analysed directly. In most cases a mixture of CD3OD and
KH2PO4 buffer in D2O (pH 6) is used, which as mentioned
previously will extract a large range of metabolites (Hendrawati
et al., 2006; Kim et al., 2005; Liang et al., 2006; Van der Kooy
et al., 2009; Widarto et al., 2006).
2.2. NMR analysis
After the extracts have been prepared, NMR analysis is carried
out to obtain a 1H NMR spectrum. The 1H NMR spectra are a
wealthy source of information of the content of metabolites in
plant samples due to the relatively high sensitivity and widespread
occurrence of protons in organic metabolites (Kim et al., 2006).
It is not important to have large quantities of plant material
for NMR metabolomics. Using 10–50 mg of plant material is
sufficient to generate a 1H NMR spectrum within 10 min. From
this NMR spectrum that could contain approximately 50–100
metabolites, it is usually possible to identify in the region of 10–20
known compounds (Kim et al., 2006).
The NMR spectra (Fig. 3) are recorded in deuterated solvents
on an NMR spectrometer (preferably 400 MHz or higher) that is
operated at a proton NMR frequency corresponding to the
specific spectrometer. For each sample a number of scans are
run which can range for high-quality spectra from 64 to 256.
The number of scans will depend on the magnet strength of the
NMR spectrometer, thus with the increase in magnet strength
fewer scans will be required. Two other factors to be considered
to obtain high-quality spectra are the (1) relaxation delay and (2)
pulsewidth parameters. The optimum parameters were previously
discussed in detail in the review of Pauli et al. (2005) and focussed
on important factors like locking, tuning and shimming which are
non-negotiable steps when it comes to reproducible metabolomics
analysis. It is important that the NMR spectra are corrected for any
baseline and phase distortions. The spectra need to be normalised
and correctly scaled and this is done by using either an internal
standard (e.g. trimethylsilyl propionic acid, tetramethylsilane, etc.)
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peak. The normalisation of the spectral areas is done to compensate
for differences in the overall concentration due to variation during
extraction. Multivariate analysis is then performed on the normal-
ised NMR spectra (Wang et al., 2004).
When working with samples that have a residual water peak, it
is very important to suppress this signal to allow for proper
spectral analysis. Pre-saturation of the residual water peak is
achieved by either (1) pre-saturating with an additional pulse, or
(2) addition of paramagnetic ions (e.g. Mg2+). The most common
method used is pre-saturation using an additional pulse, but this
has the disadvantage of an unwanted reduction of the signal
intensity close to the suppressed water peak (Beckwith-Hall et al.,
2003).
NMR data manipulation starts with splitting the data into
distinct regions (also called ‘bins’ or ‘buckets’) that normally cover
areas of approximately 0.01 to 0.04 ppm in width. These distinct
areas in turn are converted into a list of values for each spectrum.
This might seem counterproductive in that it will reduce the
resolution, but it has the added advantage of not being influenced
by chemical shift changes between repetitions and other samples
that could occur due to pH variations of the samples. The practice
of using all the data points in an NMR spectrum is starting to
gain momentum and with special algorithms that align the
peaks, eliminating any unwanted variation, the use of all data
points will become a much more common practice (Ward and
Beale, 2006).
2.3. Multivariate data analysis
One of the most important steps in metabolomics, metabolite
fingerprinting and metabolic profiling is the data analysis step
and the significance of bioinformatics as a tool should not be
underestimated.
NMR bucketed data is initially analysed using the Principal
Component Analysis (PCA) multivariate statistical method or
other similar statistical methods. The PCA statistical method is
used to make the large datasets easier to be interpreted by making
the data more visually comprehensible (Ward and Beale, 2006).
PCA was designed to extract and display the methodical variation
in a dataset. The partial least squares projections to latent structure
(PLS) analysis method is a regression extension of PCA, thus
revealing the correlations between two kinds of datasets. For the
analysis of raw analytical data, both PCA and PLS as multivariate
data analysis (MVA) programmes are becoming everyday pro-
cessing steps. The PCA and other related multivariate analyses
can be carried out by quite a few commercially available software
products. One software product often used is that of Umetrics,
SIMCA-P (Umetrics, Umea, Sweden) (Ward and Beale, 2006).
PCA models are best displayed as a scoring plot (Fig. 4). This
illustration of a scoring plot is an example of an unsupervised
comparison of samples of Artemisia afra, A. annua and a herbal
remedy which differentiated on the basis of their chemical
composition. The use of scoring plots is very valuable for the
observation of any groupings in a dataset; it is also possible to
identify outliers that could skew the plots due to errors in ex-
perimental conditions, instrumental parameters or errors in thepreparation of the samples (Van der Kooy et al., 2009). To obtain
these PCA scoring plot values, the original variable of the NMR/
MS data is multiplied with coefficients which are referred to as
loadings. The specific numerical value that the loading has will
be indicative of the relationship between the original variable and
the component (Massart et al., 1988). It is thus possible to say that
the ‘loading plots’ can highlight the spectral regions responsible
for the separation in the data and are thus responsible for the
specific position of the scoring plots (Ward and Beale, 2006).
It is important to keep inmind that before PCA the data must be
scaled appropriately. This is to insure that the spectral data
obtained is represented correctly in the MVA and that the results
obtained from MVA can be correlated back to the original NMR
spectra or MS chromatograms. When applying unit variance
scaling to NMR data, it will be difficult to interpret the loading
plots obtained due to the fact that all signals will have the same
variance/weight and as a result will be different from the original
NMR spectra orMS chromatograms.When applying scaling to the
data of plant extracts, it is necessary to use different scaling than the
unit variance scaling. The signals of the secondary metabolites can
easily be underestimated when compared to the high levels of
primary metabolites. It will thus be more appropriate to use a
scaling technique called ‘Pareto scaling’ (PAR). PAR scaling is
becoming a common scaling method for secondary metabolites
studies as PAR scaling gives each variable a variance numerically
equal to its initial standard deviation instead of unit variance.
PAR scaling not only gives weight to minor signals but also gives
interpretable loadings (Colquhoun, 2007).
3. Application of NMR-based metabolomics in natural
products
3.1. NMR-based metabolomics in QC of fruit juice
Bruker BioSpin GmbH and SGF International recently
published results from an application that was developed for QC
of fruit juices in industry. The major reasons for this investigation
were the constant challenges that the food and lifestyle industries
face in analysing the presence of specific ingredients in samples,
contamination of samples and incorrect labelling of products.
Bruker and SGF International introduced the combination of NMR
spectroscopy and multivariate analysis to analyse fruit juices sam-
ples. This resulted in a successful application technique, “Bruker
JuiceScreener™” and “SGF Profiling™” for the profiling of fruit
juices (Rinke et al., 2007).
In SGF Profiling™ each fruit juice is analysed on a multitude
of parameters that are related to the quality of the fruit juice on a
fully automated platform. Thus from a single NMR dataset that
is acquired within a few minutes numerous parameters can be
evaluated simultaneously to establish the quality and authenticity
of the specific fruit juice. The SGF Profiling™ NMR screening
has a low cost-per-sample approach and compares very well with
conventional and targeted fruit juice QC approaches (Rinke et al.,
2007).
Bruker and SGF International evaluated fruit juices with a
targeted as well as non-targeted approach. The targeted approach's
primary interest was to focus on the classical fruit juices procedure
Fig. 4. PCA scoring plot illustrating the clear differentiation in PC1 between the Artemisia annua (circles) samples and the A. afra (crosses) samples and the herbal
capsules (boxes) (Van der Kooy et al., 2008).
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specified ingredients. It is thus important to identify the presence
of a specified ingredient and its concentration. The advantages that
NMR spectroscopy has over classical analysis techniques were
clearly shown. NMR spectroscopy allows simultaneous identifi-
cation and quantification of many compounds in a mixture. The
particular quantification method provided absolute concentrations
for more than 28 different compounds depending on the type of
fruit juice. The large amount of data obtained from one single
measurement enables the detection of contaminates, adulterants,
etc. in the fruit juices (Rinke et al., 2007).
The non-targeted approach was used in cooperation with a
large reference database of more than 5 000 samples of more than
30 different fruit juice samples from more than 50 countries. The
NMR predicting model was able to determine the specific type of
fruit, product type (pure fruit juice or juicemade from concentrate),
fruit content as well as the country of origin of the juice. In Fig. 5,
the verification analysis is demonstrated which compared an apple
juice sample with the distribution of the spectra from the database
of apple juice. The deviations from normality as shown in Fig. 5B
indicated an unknown contaminant by comparing the test sample
with high phlorin concentrations to that of the database spectra
with a non-targeted analysis approach (Spraul et al., 2008).
3.2. Analysis of complex pharmaceutical preparations using
NMR metabolomics
In the commercial industry of herbal medicine, the preparations
are typically very complex and have a multitude of compounds.
The relationship of the content and the pharmacological effect
of herbal medicine is also usually unclear, but these herbal
medicine formulations are usually standardised using single
marker compounds or a group of related compounds which does
not include information on other seemingly unimportant abundant
constituents present in the herbal preparation (Rasmussen et al.,
2006).The work done by Rasmussen et al. (2006), explored the
complex pharmaceutical preparation of St. John's Wort
(Hypericum perforatum). Their investigation showed the
possibility of NMR spectroscopy and multivariate analysis
being used to distinguish between different variations in batches
from the same supplier. No clustering was observed between the
tablets and capsules thus indicating that variability between
samples is mainly contributed by plant extract variability and not
the manufacturing processes. NMR metabolomics was also able
to showmajor variations in the content of the flavonoids linked to
the antidepressant activity of the H. perforatum extract.
The study also investigated the use of two NMR solvents
(methanol-d4 and DMSO-d6) which showed to be very similar
and revealed complementary datasets, thus making it possible to
link various aspects of the samples' composition from separate
PCA models. The analysis was also done on both integrated (+/
−200 variables) and full resolution (+/−30 000 variables) NMR
data. The full resolution data produced loading plots with more
precise information of the compounds in the extract responsible
for the clustering and possibly for the therapeutic effect, thus
indicating that full resolution NMR data could be better for PCA
analysis of complex plant extracts and HM (Rasmussen et al.,
2006).
3.3. Analysing complex Artemisia herbal medicine with NMR
metabolomics
In a study conducted by Van der Kooy et al. (2008), the use
of NMR spectroscopy in combination with PCA showed to be
very promising as a method to detect the presence of a particular
constituent in herbal extracts that was claimed to be in the
extract preparation. In this study the claim of the active anti-
malarial, artemisinin, being present in capsulesmade from A. afra
was investigated. The investigation included A. afra extracts,
A. annua extracts and capsules of the product which were all
analysed by NMR. Analyses were done on a 500 MHz Bruker
Fig. 5. (A) Non-targeted verification of the sample (black line): apple juice (~1% of spectrum), (B) orange juice with high phlorin concentration (black line —
indicating over extraction) compared to model for orange juice (Bruker BioSpin GmbH and SGF International).
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Spectra were referenced to the residual chloroform peak with a
total of 6 min analysis time per sample. NMR data was processed
and files were transferred to SIMCA-P (10.0 Umetrics, Umea,
Sweden) for PCA analysis.
In this study it was clear to observe the differences between the
three different samples. Based on the PCA data (Fig. 4), the two
plant species A. afra and A. annua can easily be differentiated
from each other, separating very well in the first PC. In PC1 the
capsules clustered together with A. afra and separated from A.
annua, thus confirming that the content of the capsules are indeed
A. afra. In PC2 the A. afra and capsule samples separated very
distinctively, with the separation being explained by the difference
in compound concentration between them. In the same study they
also showed with LC–MS data that the anti-malarial compound,
artemisinin was only detected in the A. annua samples and not in
the A. afra at all. Thus, the claimed reports of the anti-malarial
compound artemisinin being present in the capsules from A. afra
were proven to be incorrect using NMR-based metabolomics
(Van der Kooy et al., 2008).
3.4. Chemical profiling of HM
Most of the current traditional methods of QC of whole
extracts are not sufficient for application on HM. This has led to
large variation between batches of products encountered in the
market. Due to the fact that many factors can have a significant
influence on the chemical composition of phytomedicine (plant
growth environment, collection/harvesting season, preparation and
extraction process, etc.), it is vital to make sure that these factors
are considered in the QC of phytomedicine/herbal medicine (Abe
and Kamo, 2003; Bailey et al., 2002).High resolution 1HNMR can play a vital role in this regard and
combined with chemometric analysis it offers a way to assess the
whole plant extract. It provides a way to view ‘all’ the chemical
components present in a plant extract concurrently as a “metabolic
fingerprint” (Bailey et al., 2002). By applying PCA techniques to
NMR data, the differences and similarities between economical
important samples can be visualised in 2D of 3D plots very easily
and quickly (Bailey et al., 2002), thus also adding to the high-
throughput need for QC purposes.
In a study conducted by Wang et al. (2004), NMR-based
metabolomics was used to determine the global composition of
three chamomile (Matricaria recutita L.) samples gathered from
three different countries. The aimwas to differentiate these samples
on (1) the origin, (2) herb quality in terms of percentage of desired
plant parts and (3) extraction method. The study investigated the
development of a new robust QC method with the use of NMR-
based metabolomics and the development of methods to also
chemically profile phytomedicine like chamomile.
This study clearly indicated that there are significant differences
between samples from different geographical distributions which
is clearly separated in PC1 (t[1]) (Fig. 6). It was also possible to
determine the quality of the herb in terms of the percentage of stalk
contamination in the samples. When the average scores were used
as a function of the percentage of stalks it showed that the linear
relationship was an excellent fit (r2 =0.98). The final objective
was to determine the effect of the preparation and extraction.
Both preparation and extraction indicated large influences on
the chemical composition of the chamomile phytomedicine
preparation. When dried and wet plant material was compared,
large reductions in the methoxy resonance groups were experi-
enced in the wet extract and significant increases of the sugar
resonance peaks in the dried extract were observed. Lastly the
Fig. 6. PCA scoring plot (t[1] vs. t[2]) of 1H NMR spectra from different
chamomile extracts (▲) — Slovakia, (●) — Egypt, (■) — Hungary, (*) —
100% stalk, (○) — 70% stalk, (□) — 30% stalk (Wang et al., 2004).
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also shown to be significant with large separation in PC1 (Wang et
al., 2004).
In the field of plant-derived medicine conventional analytical
methods are not sufficient to cope with the complexity of such
extracts. This study on the other hand has clearly indicated the
potential of NMR-based metabolomics as an innovative QC
technique for phytomedicine and herbal medicine in general
(Wang et al., 2004).
3.5. NMR-based metabolic fingerprinting of Ephedra
A study conducted by Kim et al. (2005) on the metabolic
fingerprinting of the Ephedra genus, one of the oldest
medicinal herbs known to mankind. Ephedra sinica is known
to be the main source of the ephedrine alkaloids, but there are
other 14 species that are known to also contain ephedrine
alkaloids. Thus, the need for identification of the different
species is a necessity and the study showed that this is possible
with NMR-based metabolomics. As highlighted by this study,
previous chemotaxonomical studies focused mainly on the
small group of metabolites i.e. ephedrine alkaloids which may
be misleading and thus a broader chemical fingerprint analysis
is needed.
In the study (Kim et al., 2005) three Ephedra species (E. sinica,
Ephedra intermedia and Ephedra distachya var. distachya) were
analysed with NMR and compared with nine commercially
available Ephedra herbal plant samples purchased from a
Taiwanese market. The three known Ephedra species separated
very well in PC1, with E. distachya var. distachya separating
completely from the other two species and this was determined to
be due to no ephedrine being detected in it. Separation was best in
the aqueous extracts and thus PCA analysis was done on the
aqueous extracts only. Most of the commercial samples clusteredclose to the E. intermedia except for one species that group
between E. sinica and E. intermedia which was determined to be
a mixture of these two.
Thus, from this study it was clear that NMR-based metabo-
lomics can easily and quite conveniently be used to verify if herbal
plant material is authentic. As a large part of the world is still
making use of traditional herbal markets to obtain their primary
medicine it can be very useful to authenticate these supplies of
herbal medicine. Some herbal medicine companies also rely on
wild harvested plant material for their herbal production and thus it
is also important to validate the supplies that are received before
using it in production.
4. Future perspective of NMR-based metabolomics
4.1. Economical outlook
NMR-based metabolomics can also be used in many other
applications, i.e. food authenticity, functional genomics and also
in the substantial equivalence testing of GMO's.
NMR is robust, reliable and non-destructive and thus an
ideal companion for QC of economical important samples. NMR
spectroscopy combined with multivariate statistical analysis
software provides new opportunities for conducting sound and
reliable QC analyses on botanical samples. These samples can
range from botanical, pharmaceutical to everyday fruit juice QC
samples. In future the standardisation of HMwill probably play an
important role for approval of complex HM as a treatment and
require robust and rapid analytical methods for the QC of these
products without the tedious preparation normally necessary for
QC on complex mixtures. So in the future QC analyses will
probably not be done on a few selected constituents anymore, but
will be done on the whole composition of the sample.
In combination with functional genomics, NMR metabolomics
can assist in investigating the deeper understanding of the complex
nature of the networks operating in plants and how these networks
change due to genetic manipulation. Not only is it possible to
determine the genetic changes but also establish the fundamental
nature of the plant phenotypes in relation to development,
physiology and environment. In studies that have been conducted
it was possible to use metabolomics in determining the effects of
environmental stress on root and on specific enzyme function
(Moing et al., 2004). It is also becoming more and more the trend
to use different ‘omics’ datasets and to cross-correlate these
datasets to extract as much information out of these information
rich matrices (Ward et al., 2007).
Determining the unintended effects of genetic modification
is a very important area of research and with regulatory bodies
placing more and more emphasis on safety issues of GMO's it
is of utmost importance to use the best methods available to us.
NMR-based metabolomics is starting to gain momentum in this
field. NMR fingerprinting with the use of multivariate analysis is
a very powerful tool and has been used to identify and classify
seeds of maize, wheat etc. obtained from transgenic plants
into different classes on the basis of different metabolite
compositions. Even with the use of relatively small models it is
possible to easily explain up to 90% of the variability and the
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NMR-based metabolomics will in future contribute signif-
icantly to research in many biological fields and also to the
economical development of these fields. In the field of drug
discovery and development NMR-based metabolomics will
contribute to achieve rapid and efficient lead identification and
might in some cases be able to replace the tedious practice of
bio-guided fractionation. It can also be incorporated in the early
stages of drug discovery to rapidly identify known compounds
in the plant under investigation and not to waste any valuable
time on these known compounds, thus quickly narrowing down
the search.
4.2. Future developments in perspective
Recent advances that have been made with NMR methods
make it an appropriate technique with unique characteristics for
the analysis of plant metabolites. In spite of all the above
mentioned positive attributes of NMR-based metabolomics it is
necessary to take into account that there are a few disadvan-
tages with NMR as a technique. NMR's greatest weakness lies
in the resolution and sensitivity capabilities. Compared to MS,
NMR is lacking significantly in this area and it limits NMR-
based metabolomics to compete at low compound levels. MS
has the added advantage to be joined easily to a chromatog-
raphy unit to do combinational analysis which is not the case
with NMR where it is a more cumbersome task to combine it with
chromatography techniques. With MS analysis compounds can be
detected at very low concentrations and even at trace element level,
thus enriching the data to be used for chemometric analysis.
Chromatographic techniques assist MS detection to separate the
large amount of constituents in plant samples to assist the increased
number of constituents being analysed and identified. With NMR
the complex plant extracts cause huge overlap in most of the
spectral regions thus making it difficult to extract the necessary
information from the spectra (Kim et al., 2011).
Recent developments and trends in NMR analysis have been
highlighted in a review done by Kim et al. (2011). Developments
in hardware (e.g. high-resolution NMR, cryoprobes, microprobes)
as well as new developments in the protocols of pulse sequence
and spectral acquisition have been reviewed regarding improve-
ments in sensitivity. Kim et al. (2011) also discussed recent
approaches like 2D 1H J-resolved NMR and heteronuclear single
quantum coherence (HSQC) spectroscopy that spreads the spectral
content over a 2D plane. This makes analysis of plant samples
much easier and more informative (but more time consuming). It
therefore simplifies QC techniques and helps to identify the
common constituents in herbal samples and the quantification of
them for routine analysis.
Another improvement that has come under the spotlight is
magical angle spinning (MAS)-NMR spectroscopy. This tech-
nique requires very simple sample preparation (e.g. direct in-
sertions of lyophilised tissue on a MAS 4-mm zirconium rotor)
with very little deuterated solvent (20 μl), thus having a dual
benefit of no sample preparation problems and small amounts of
expensive solvents are consumed. Samples are then analysed on a54.7° angle (the magic angle) which reduces line broadening
significantly and a high resolution spectrum is obtained. This has
the benefit that samples do not run the danger of being altered due
to chemical reactions during sample preparation (Kim et al.,
2011).
5. Conclusion
Taking all of the above into account, NMR-based metabolo-
mics has some limitations which are the topic of intense current
research, but it is evident that it could contribute quite significantly
to the QC of HM. The added advantage that can be gained from
NMR-based metabolomics above other traditional QC methods is
that firstly it analyses all the compounds in the sample thus giving
a holistic view of the HM. It has the capability to differentiate
between samples from different origins, harvested in different
seasons, grown in different soil types, with different plant parts
composition, with added adulterance etc. and therefore is more
reliable than the normal narrowly focused TLC or HPLC QC
methods.
The regulative environment is becoming increasingly more
stringent and will in future require a much better and more in-
depth analysis of what is being put on the HMmarket. Traditional
QC methods give a restricted view of the contents of the product,
but with NMR-based metabolomics much more detail will be
available, thereby improving reliability.
In South Africa the regulative environment of the HM market
is due for a revision as there are very limited regulative conditions
for HM to reach the market. The South African market has a
potential to be developed to an international level. From a review
of Van Wyk (2008), it is very clear that southern Africa does not
lack any potential candidates that can be used and are already
used commercially. Having economical species like round leaf
buchu (Agathosma betulina), rooibos (Aspalathus linearis), wild
wormwood (A. afra), Cape aloe (Aloe ferox), fever tea (Lippia
javanica) just to mention a few, gives southern Africa a huge
advantage to compete in the HM industry. It is now up to the HM
industry to regulate the HM cultivation and production and with
the correct QC capabilities to ensure that these authentic HM
products reach the market.
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